Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 3 minute read Pharma Industry News CStone Pharmaceuticals advances cancer research with first-in-human clinical trial application for CS2009 CStone Pharmaceuticals, an innovation-driven biopharmaceutical company listed on the Hong Kong Stock Exchange (HKEX: 2616), has taken a… byPallavi MadhirajuDecember 23, 2024